| Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens (NCT07631897) | Shanghai Public Health Clinical Center | 2026-06-01 |
| Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma (NCT07727642) | Shanghai Public Health Clinical Center | 2026-05-26 |
| Short-Course Regimens for DS-PTB in AIDS Patients (NCT07608172) | Shanghai Public Health Clinical Center | 2026-05-25 |
| Real-world Cohort Study of Antiretroviral Therapy in HIV Patients With Opportunistic Infections (NCT07526363) | Shanghai Public Health Clinical Center | 2026-05-01 |
| Prevention of AIDS With Opportunistic Infection Paradoxical IRIS (NCT07565623) | Shanghai Public Health Clinical Center | 2026-05-01 |
| Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS (NCT07579247) | Shanghai Public Health Clinical Center | 2026-05-01 |
| Enhanced Treatment Strategy for Disseminated MAC Infection in HIV Patients: A Randomized Controlled Trial (NCT07585461) | Shanghai Public Health Clinical Center | 2026-04-30 |
| Incidence of Liver Disease-Related Outcomes in People With HIV (NCT06940375) | Shanghai Public Health Clinical Center | 2025-07-01 |
| Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis (NCT06926569) | Shanghai Public Health Clinical Center | 2025-05-01 |
| Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant (NCT06768697) | Shanghai Public Health Clinical Center | 2024-12-30 |
| Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity (NCT05493969) | Shanghai Public Health Clinical Center | 2022-08-01 |
| Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression (NCT05129189) | Shanghai Public Health Clinical Center | 2022-06-29 |
| Study of MDW Levels Predicting the Development of Sepsis in Hospitalized HIV-infected Patients and Correlation With Prognosis (NCT05036928) | Shanghai Public Health Clinical Center | 2021-12-01 |
| Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 (NCT05038449) | Shanghai Public Health Clinical Center | 2021-09-06 |
| Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder (NCT04963712) | Shanghai Public Health Clinical Center | 2021-09-01 |
| Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease (NCT04779359) | Shanghai Public Health Clinical Center | 2021-04-01 |
| Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients (NCT04513379) | Shanghai Public Health Clinical Center | 2020-11-01 |
| TB-LAM in the Diagnosis of TB (NCT04600232) | Shanghai Public Health Clinical Center | 2020-10-01 |
| Euphorbia Kansui and HIV/AIDS Functional Cure (NCT04503928) | Shanghai Public Health Clinical Center | 2020-08-01 |
| Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 (NCT04261517) | Shanghai Public Health Clinical Center | 2020-02-06 |
| Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 (NCT04292340) | Shanghai Public Health Clinical Center | 2020-02-01 |
| Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 (NCT04252274) | Shanghai Public Health Clinical Center | 2020-01-30 |
| AmB Dose for Cryptococcal Meningitis (NCT04140461) | Shanghai Public Health Clinical Center | 2020-01-02 |
| NAFLD in HIV-infected Patients (NCT04215926) | Shanghai Public Health Clinical Center | 2019-12-05 |
| The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects (NCT04006353) | Shanghai Public Health Clinical Center | 2019-07-11 |
| Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis (NCT03478033) | Shanghai Public Health Clinical Center | 2018-04-15 |
| Optimization of Antiretroviral Therapy (NCT02935075) | Shanghai Public Health Clinical Center | 2018-03-05 |
| Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy (NCT02945163) | Shanghai Public Health Clinical Center | 2018-03-05 |
| An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients. (NCT03517631) | Shanghai Public Health Clinical Center | 2018-02-27 |
| Gut Microbiota and Immune Recovery (NCT03478540) | Shanghai Public Health Clinical Center | 2017-12-01 |